Quick Answer
MUSTANG BIO, INC. reported Net Income of -$1.92 million for fiscal year 2025.
MUSTANG BIO, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | -$1.92M +87.8% |
-$15.75M +69.5% |
-$51.60M +33.4% |
-$77.53M -16.8% |
-$66.37M -10.6% |
-$60.02M -29.4% |
| Diluted EPS | -$0.39 +99.0% |
-$38.57 +87.1% |
-$299.95 -2872.7% |
-$10.09 -1227.6% |
-$0.76 | — |
| Total Assets | $17.59M +89.0% |
$9.31M -47.5% |
$17.74M -80.8% |
$92.42M -26.2% |
$125.17M +13.9% |
$109.90M +49.6% |
| Cash and Equivalents | $17.27M +152.5% |
$6.84M +9.7% |
$6.23M -91.8% |
$75.66M -31.0% |
$109.62M +12.1% |
$97.80M +59.3% |
| Stockholders Equity | $9.53M +346.0% |
-$3.87M -3248.8% |
$123.0K -99.7% |
$46.27M -58.8% |
$112.40M +14.2% |
$98.44M +90.6% |
| Operating Income | -$2.43M +85.0% |
-$16.25M +67.0% |
-$49.26M +35.3% |
-$76.16M -14.1% |
-$66.72M -17.5% |
-$56.81M -23.8% |
| Shares Outstanding | — | — | — | — | — | 70.92M +80.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$468.0K | +66.8% | +38.6% |
| Diluted EPS | September 30, 2025 | -$0.07 | +96.4% | +63.2% |
| Total Assets | September 30, 2025 | $19.36M | +169.2% | +48.4% |
| Cash and Equivalents | September 30, 2025 | $18.98M | +438.6% | +50.0% |
| Stockholders Equity | September 30, 2025 | $9.77M | +212.9% | +237.9% |
| Operating Income | September 30, 2025 | -$624.0K | +57.2% | +29.5% |
| Shares Outstanding | September 30, 2022 | 106.43M | +16.7% | +1.8% |
- MUSTANG BIO, INC. reported Net Income of -$1.92 million for fiscal year 2025.
- MUSTANG BIO, INC. showed an increase of +87.8% in Net Income compared to the prior fiscal year.
- MUSTANG BIO, INC. reported Diluted EPS of $0.39 per share (loss) for fiscal year 2025.
- MUSTANG BIO, INC. showed an increase of +99.0% in Diluted EPS compared to the prior fiscal year.
- MUSTANG BIO, INC. reported Total Assets of $17.59 million for fiscal year 2025.
- MUSTANG BIO, INC. showed an increase of +89.0% in Total Assets compared to the prior fiscal year.
- MUSTANG BIO, INC. reported Cash and Equivalents of $17.27 million for fiscal year 2025.
- MUSTANG BIO, INC. showed an increase of +152.5% in Cash and Equivalents compared to the prior fiscal year.
- MUSTANG BIO, INC. reported Stockholders Equity of $9.53 million for fiscal year 2025.
- MUSTANG BIO, INC. showed an increase of +346.0% in Stockholders Equity compared to the prior fiscal year.
- MUSTANG BIO, INC. reported Operating Income of -$2.43 million for fiscal year 2025.
- MUSTANG BIO, INC. showed an increase of +85.0% in Operating Income compared to the prior fiscal year.
- MUSTANG BIO, INC. reported Shares Outstanding of 70.92 million shares for fiscal year 2020.
- MUSTANG BIO, INC. showed an increase of +80.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: